"Whisper Numbers" Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : "Whisper Numbers"

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: drmicrocap	5/3/2016 11:56:19 AM
	of 199

6:37 am Clorox beats by $0.11, beats on revs; raises FY16 guidance ( CLX) : Reports Q3 (Mar) earnings of $1.21 per share, $0.11 better than the Capital IQ Consensus of $1.10; revenues rose 1.8% year/year to $1.43 bln vs the $1.41 bln Capital IQ Consensus.Co issues raises guidance for FY16, sees EPS of $4.85-4.95 vs. $4.92 Capital IQ Consensus Estimate, up from previous outlook of $4.75 to $4.90. Raises sales growth outlook to 1% to 2% sales growth, or 4% to 5% currency-neutral (previously flat to 1% growth, 3% to 4% currency neutral). Revenue consensus represents +0.8% growth. CLX now sees about 50 basis points of EBIT margin expansion (previously 50-75 basis points). Third-quarter diluted EPS results were driven largely by gross margin expansion and higher sales, partially offset by higher advertising and sales promotion spending and the impact of unfavorable foreign currency exchange rates.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next